This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Maastricht University, Rheinische Friedrich-Wilhelms-Universitat Bonn. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: **Inventor Spotlight: Joschka Buyel**
Introduction
Joschka Buyel is an innovative inventor based in Cologne, Germany. He has made significant contributions to the field of biotechnology, particularly in the understanding and diagnosis of brown and beige fat tissues. His work has the potential to influence how we approach obesity and metabolic disorders.
Latest Patents
Buyel holds a patent titled "Exosomal microRNA in serum as an indicator for the activation of brown and beige fat tissue (BAT)." This invention provides methods for detecting the activation of brown and beige adipose tissues in biological samples. Specifically, it involves measuring the amount of miR-92 in the sample, which can serve as a diagnostic marker for metabolic health. The methods outlined in the patent have various clinical applications, indicating their potential impact in medical diagnostics.
Career Highlights
Throughout his career, Joschka Buyel has worked with prestigious research institutions such as the Rheinische Friedrich-Wilhelms-Universität Bonn and Maastricht University. These roles have contributed significantly to his development as an inventor and researcher, allowing him to explore cutting-edge research in the field of metabolic studies.
Collaborations
Joschka Buyel has collaborated with notable researchers including Alexander Pfeifer and Yong Chen. These partnerships have facilitated the exchange of ideas and expertise, further advancing the research in the area of brown and beige fat tissue activation.
Conclusion
Joschka Buyel is a prominent figure in the field of biotechnology with a focused approach on the role of microRNA in fat tissue metabolism. His patent not only marks a significant milestone in his career but also opens new avenues for research and clinical applications that may positively impact public health. The potential of his work serves as an inspiration for future innovations in metabolic health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile